Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis

Fingolimod is an approved treatment for relapsing–remitting multiple sclerosis (MS), and its properties in different pathways have raised interest in therapy research for other neurodegenerative diseases. Fingolimod is an agonist of sphingosine-1-phosphate (S1P) receptors. Its main pharmacologic eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Bascuñana, Pablo, Möhle, Luisa, Brackhan, Mirjam, Pahnke, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419396/
https://www.ncbi.nlm.nih.gov/pubmed/32696271
http://dx.doi.org/10.1007/s40268-020-00316-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419396/
https://www.ncbi.nlm.nih.gov/pubmed/32696271
http://dx.doi.org/10.1007/s40268-020-00316-1

Ejemplares similares